1. Home
  2. UVE vs ALVO Comparison

UVE vs ALVO Comparison

Compare UVE & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UNIVERSAL INSURANCE HOLDINGS INC

UVE

UNIVERSAL INSURANCE HOLDINGS INC

HOLD

Current Price

$43.57

Market Cap

1.2B

Sector

Finance

ML Signal

HOLD

Logo Alvotech

ALVO

Alvotech

HOLD

Current Price

$4.05

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UVE
ALVO
Founded
1990
2013
Country
United States
Luxembourg
Employees
N/A
1460
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.0B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
UVE
ALVO
Price
$43.57
$4.05
Analyst Decision
Buy
Buy
Analyst Count
1
4
Target Price
$40.00
$8.00
AVG Volume (30 Days)
222.8K
698.9K
Earning Date
04-23-2026
05-06-2026
Dividend Yield
1.97%
N/A
EPS Growth
214.43
N/A
EPS
3.93
N/A
Revenue
$1,603,915,000.00
N/A
Revenue This Year
N/A
$13.28
Revenue Next Year
$2.88
$18.63
P/E Ratio
$23.43
$18.20
Revenue Growth
5.48
N/A
52 Week Low
$22.87
$2.94
52 Week High
$45.15
$9.25

Technical Indicators

Market Signals
Indicator
UVE
ALVO
Relative Strength Index (RSI) 59.20 59.65
Support Level $29.85 $3.65
Resistance Level $43.68 $3.94
Average True Range (ATR) 1.60 0.19
MACD 0.43 0.05
Stochastic Oscillator 79.50 96.48

Price Performance

Historical Comparison
UVE
ALVO

About UVE UNIVERSAL INSURANCE HOLDINGS INC

Universal Insurance Holdings Inc is an insurance holding company. Through its subsidiaries, the company mainly offers property and casualty insurance and value-added insurance services. It develops, markets, and underwrites insurance products for consumers predominantly in the personal residential homeowners lines of business and performs all other insurance-related services for its primary insurance entities, including risk management, claims management, and distribution. The group offers the following types of personal residential insurance: homeowners, renters/tenants, condo unit owners, and dwelling/fire, through an independent agent network and online distribution channels across multiple states in the United States of America.

About ALVO Alvotech

Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.

Share on Social Networks: